Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Semaglutide

STEP 6

Novo Nordisk · Phase 3 · Completed · Enrollment 401

NCT03811574

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Semaglutide 2.4 mgn/rn/rn/rn/rn/r
Placebo (semaglutide 2.4 mg)35 participants17 participants32 participantsn/r0
Semaglutide 1.7 mgn/rn/rn/rn/rn/r
Placebo (semaglutide 1.7 mg)18 participants10 participants22 participantsn/r0

A count stays a count. This page does not turn a count into a percent.